Ueda, T., Uemura, H., Tomita, Y., Tsukamoto, T., Kanayama, H., Shinohara, N., . . . Akaza, H. (2013). Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 3 AXIS Trial. Oxford University Press.
Citação norma ChicagoUeda, Takeshi, et al. Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients From the Global Randomized Phase 3 AXIS Trial. Oxford University Press, 2013.
MLA CitationUeda, Takeshi, et al. Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients From the Global Randomized Phase 3 AXIS Trial. Oxford University Press, 2013.